Agios Pharmaceuticals Inc (AGIO)
31.81
+1.60
(+5.30%)
USD |
NASDAQ |
Apr 23, 16:00
31.81
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Max Drawdown (5Y): 82.86% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 82.86% |
| February 29, 2024 | 82.86% |
| January 31, 2024 | 82.86% |
| December 31, 2023 | 82.86% |
| November 30, 2023 | 82.86% |
| October 31, 2023 | 82.86% |
| September 30, 2023 | 82.86% |
| August 31, 2023 | 82.86% |
| July 31, 2023 | 82.86% |
| June 30, 2023 | 82.86% |
| May 31, 2023 | 82.86% |
| April 30, 2023 | 82.86% |
| March 31, 2023 | 82.86% |
| February 28, 2023 | 82.86% |
| January 31, 2023 | 82.86% |
| December 31, 2022 | 82.86% |
| November 30, 2022 | 82.86% |
| October 31, 2022 | 82.86% |
| September 30, 2022 | 82.86% |
| August 31, 2022 | 82.86% |
| July 31, 2022 | 82.86% |
| June 30, 2022 | 82.86% |
| May 31, 2022 | 80.52% |
| April 30, 2022 | 77.93% |
| March 31, 2022 | 77.72% |
| Date | Value |
|---|---|
| February 28, 2022 | 77.72% |
| January 31, 2022 | 77.72% |
| December 31, 2021 | 77.72% |
| November 30, 2021 | 77.72% |
| October 31, 2021 | 77.72% |
| September 30, 2021 | 77.72% |
| August 31, 2021 | 77.72% |
| July 31, 2021 | 77.72% |
| June 30, 2021 | 77.72% |
| May 31, 2021 | 77.72% |
| April 30, 2021 | 77.72% |
| March 31, 2021 | 77.72% |
| February 28, 2021 | 77.72% |
| January 31, 2021 | 77.72% |
| December 31, 2020 | 77.72% |
| November 30, 2020 | 77.72% |
| October 31, 2020 | 77.72% |
| September 30, 2020 | 77.72% |
| August 31, 2020 | 77.72% |
| July 31, 2020 | 77.72% |
| June 30, 2020 | 77.72% |
| May 31, 2020 | 77.72% |
| April 30, 2020 | 77.72% |
| March 31, 2020 | 77.72% |
| February 29, 2020 | 77.72% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.51%
Minimum
Apr 2019
82.86%
Maximum
Jun 2022
79.28%
Average
77.72%
Median
Oct 2019
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals Inc | 54.98% |
| Blueprint Medicines Corp | 69.50% |
| Corcept Therapeutics Inc | 61.61% |
| Ionis Pharmaceuticals Inc | 70.27% |
| Madrigal Pharmaceuticals Inc | 82.20% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -28.18 |
| Beta (5Y) | 0.8264 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 49.56% |
| Historical Sharpe Ratio (5Y) | -0.3509 |
| Historical Sortino (5Y) | -0.644 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.26% |